CINGW

Cingulate Inc. warrants are derivative securities that give holders the right to purchase shares of Cingulate Inc. common stock at a predetermined price within a specified time period. These warrants were typically issued in connection with financing transactions or public offerings to provide additional value to investors. Cingulate is a biopharmaceutical company developing treatments for ADHD and anxiety disorders using proprietary drug delivery technology. Warrants allow investors to participate in potential upside if the company's stock price appreciates above the exercise price before expiration.